125 related articles for article (PubMed ID: 34993530)
21. Development of a novel nanoparticle by dual modification with the pluripotential cell-penetrating peptide PepFect6 for cellular uptake, endosomal escape, and decondensation of an siRNA core complex.
Mitsueda A; Shimatani Y; Ito M; Ohgita T; Yamada A; Hama S; Gräslund A; Lindberg S; Langel Ü; Harashima H; Nakase I; Futaki S; Kogure K
Biopolymers; 2013 Nov; 100(6):698-704. PubMed ID: 23893316
[TBL] [Abstract][Full Text] [Related]
22. Carboplatin prodrug conjugated Fe
Song H; Quan F; Yu Z; Zheng M; Ma Y; Xiao H; Ding F
J Mater Chem B; 2019 Jan; 7(3):433-442. PubMed ID: 32254730
[TBL] [Abstract][Full Text] [Related]
23. The combination of endolysosomal escape and basolateral stimulation to overcome the difficulties of "easy uptake hard transcytosis" of ligand-modified nanoparticles in oral drug delivery.
Cui Y; Shan W; Zhou R; Liu M; Wu L; Guo Q; Zheng Y; Wu J; Huang Y
Nanoscale; 2018 Jan; 10(3):1494-1507. PubMed ID: 29303184
[TBL] [Abstract][Full Text] [Related]
24. Delivery of 5'-triphosphate RNA with endosomolytic nanoparticles potently activates RIG-I to improve cancer immunotherapy.
Jacobson ME; Wang-Bishop L; Becker KW; Wilson JT
Biomater Sci; 2019 Jan; 7(2):547-559. PubMed ID: 30379158
[TBL] [Abstract][Full Text] [Related]
25. Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.
Huang ZR; Tipparaju SK; Kirpotin DB; Pien C; Kornaga T; Noble CO; Koshkaryev A; Tran J; Kamoun WS; Drummond DC
J Control Release; 2019 Sep; 310():47-57. PubMed ID: 31400383
[TBL] [Abstract][Full Text] [Related]
26. Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy.
Liang DS; Liu J; Peng TX; Peng H; Guo F; Zhong HJ
Colloids Surf B Biointerfaces; 2018 Dec; 172():506-516. PubMed ID: 30212688
[TBL] [Abstract][Full Text] [Related]
27. Understanding the Biological Interactions of pH-Swellable Nanoparticles.
Kermaniyan SS; Chen M; Zhang C; Smith SA; Johnston APR; Such C; Such GK
Macromol Biosci; 2022 May; 22(5):e2100445. PubMed ID: 35182032
[TBL] [Abstract][Full Text] [Related]
28. Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.
He X; Cai K; Zhang Y; Lu Y; Guo Q; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Li C; Sun T; Cheng J; Jiang C
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39455-39467. PubMed ID: 30362704
[TBL] [Abstract][Full Text] [Related]
29. Biomechanics and thermodynamics of nanoparticle interactions with plasma and endosomal membrane lipids in cellular uptake and endosomal escape.
Peetla C; Jin S; Weimer J; Elegbede A; Labhasetwar V
Langmuir; 2014 Jul; 30(25):7522-32. PubMed ID: 24911361
[TBL] [Abstract][Full Text] [Related]
30. Conjugation of Oligo-His Peptides to Magnetic γ-Fe
Le Jeune M; Secret E; Trichet M; Michel A; Ravault D; Illien F; Siaugue JM; Sagan S; Burlina F; Ménager C
ACS Appl Mater Interfaces; 2022 Apr; 14(13):15021-15034. PubMed ID: 35319860
[TBL] [Abstract][Full Text] [Related]
31. Fluorescence microscopy colocalization of lipid-nucleic acid nanoparticles with wildtype and mutant Rab5-GFP: A platform for investigating early endosomal events.
Majzoub RN; Chan CL; Ewert KK; Silva BF; Liang KS; Safinya CR
Biochim Biophys Acta; 2015 Jun; 1848(6):1308-18. PubMed ID: 25753113
[TBL] [Abstract][Full Text] [Related]
32. Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery.
Huang JL; Chen HZ; Gao XL
J Drug Target; 2018; 26(5-6):398-406. PubMed ID: 29258343
[TBL] [Abstract][Full Text] [Related]
33. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells.
Braga CB; Perli G; Becher TB; Ornelas C
Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218
[TBL] [Abstract][Full Text] [Related]
34. Optimization of Curcumin-Loaded PEG-PLGA Nanoparticles by GSH Functionalization: Investigation of the Internalization Pathway in Neuronal Cells.
Paka GD; Ramassamy C
Mol Pharm; 2017 Jan; 14(1):93-106. PubMed ID: 27744707
[TBL] [Abstract][Full Text] [Related]
35. Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy.
Valencia PM; Pridgen EM; Rhee M; Langer R; Farokhzad OC; Karnik R
ACS Nano; 2013 Dec; 7(12):10671-80. PubMed ID: 24215426
[TBL] [Abstract][Full Text] [Related]
36. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
[TBL] [Abstract][Full Text] [Related]
37. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
Chen G; Wang Y; Xie R; Gong S
J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
[TBL] [Abstract][Full Text] [Related]
38. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
Xu M; Qian J; Liu X; Liu T; Wang H
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
[TBL] [Abstract][Full Text] [Related]
39. Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles.
Selby LI; Cortez-Jugo CM; Such GK; Johnston APR
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28160452
[TBL] [Abstract][Full Text] [Related]
40. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
